NASDAQ:BIB
ProShares Ultra Nasdaq Biotechnology ETF News
$52.58
+2.13 (+4.22%)
At Close: May 01, 2024
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Bought by Capital Investment Advisors LLC
07:44am, Wednesday, 22'nd Jul 2020
Capital Investment Advisors LLC raised its holdings in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) by 28.4% during the 2nd quarter, according to the company in its most recent Form 13F filing wi
Tower Research Capital LLC TRC Sells 20,453 Shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)
07:13am, Saturday, 04'th Jul 2020
Tower Research Capital LLC TRC cut its stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) by 95.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange
The biotech sector as a safe bet for investments during the crisis
02:00pm, Monday, 29'th Jun 2020
Biotechnology companies have many growth levers and are to be favored for their defensive qualities, in the context of the health and economic crisis.
Health Care Up On Biotech Demand -- Health Care Roundup | MarketScreener
09:25pm, Thursday, 25'th Jun 2020Health Care Down, But Not By Much, Amid Defensive Bias -- Health Care Roundup
09:02pm, Wednesday, 24'th Jun 20202 Biotech Stocks With Major Incoming Catalysts | The Motley Fool
10:49am, Wednesday, 24'th Jun 2020
While everyone's focused on COVID-19, these drugmakers are looking forward to unrelated FDA approvals that could push their stock prices into the clouds.
4 Best-Performing Leveraged ETF Areas of Last Week
05:00pm, Monday, 22'nd Jun 2020
Last week witnessed a tug-of-war between bulls and bears.
Nasdaq Stock Exchange president on IPO outlook amid COVID-19
07:28pm, Thursday, 07'th May 2020
Nasdaq Stock Exchange President Nelson Griggs joins Yahoo Finance’s Seana Smith to discuss market operations amid the coronavirus and the outlook on IPOs.
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Acquired by Ladenburg Thalmann Financial Services Inc.
09:06am, Saturday, 25'th Apr 2020
Ladenburg Thalmann Financial Services Inc. lifted its position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) by 500.0% in the fourth quarter, Holdings Channel reports. The institution
ING's Latest Economic Views And Forecasts
07:52pm, Monday, 16'th Mar 2020
Our gut feeling is that this will not be the last update. US: We are penciling in an 8.0% annualised 2Q20 GDP decline. Europe: Bund yields will likely continue
novio shares continue volatile trading as analysts say they believe in its technology
02:12pm, Sunday, 15'th Mar 2020
Shares of biotech Inovio Pharmaceuticals Inc. fell more than 20% Friday, as analysts weighed in on the company’s latest earnings and RBC downgraded the stock on valuation grounds.
FBIOX or FBDIX: Which Biotech Fund Should You Buy?
03:10pm, Friday, 13'th Mar 2020
The urgent need for a vaccine for coronavirus has sent biotech companies actively developing one, making biotechnology funds attractive.
Dems attack Trump over stalled efforts to lower drug prices
02:32pm, Friday, 21'st Feb 2020
High drug prices will, again, be a key issue in the 2020 Presidential campaign considering that President Trump has made scant progress on the matter despite much rhetoric.White House press secretary
Drugmakers getting creative over ways to pay for pricey meds
05:16pm, Monday, 13'th Jan 2020
Faced with pushback from multiple fronts over high drug prices, biopharmaceutical firms are experimenting with new ways to get paid for their priciest offerings, mostly biologics, in a report from the
